Table 1 Characteristics of the study population, according to clinical groups, and stratified by sex
Total (n = 577) | Healthy (n = 112) | Survivors of blood disorders (n = 229) | Lung fibrosis (n = 148) | Lung TX (n = 88) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Female (n = 257) | Male (n = 320) | Female (n = 67) | Male (n = 45) | Female (n = 118) | Male (n = 111) | Female (n = 33) | Male (n = 115) | Female (n = 39) | Male (n = 49) | ||
Age | 42 (16) | 48 (18) | 42 (15) | 39 (11) | 33 (10) | 32 (109 | 66 (6) | 65 (9) | 52 (13) | 55 (9) | |
FVC (L) | 3.6 (0.8) | 4.4 (1.3) | 4.0 (0.6) | 5.8 (0.8) | 3.8 (0.6) | 5.2 (1.0) | 2.4 (0.6) | 3.2 (0.7) | 3.3 (0.7) | 3.9 (1.0) | |
FEV1 (L) | 2.9 (0.7) | 3.4 (1.1) | 3.2 (0.6) | 4.5 (0.7) | 3.0 (0.6) | 4.1 (0.8) | 1.9 (0.5) | 2.6 (0.5) | 2.5 (0.6) | 2.7 (0.9) | |
FEV1/FVC | 0.80 (0.08) | 0.78 (0.10) | 0.79 (0.07) | 0.77 (0.06) | 0.81 (0.08) | 0.79 (0.09) | 0.79 (0.07) | 0.80 (0.07) | 0.79 (0.11) | 0.69 (0.16) | |
DLCO (SI-unit) | 6.9 (2) | 8.2 (3.4) | 8.1 (1.3) | 11.6 (1.8) | 7.5 (1.4) | 10.9 (2.0) | 3.8 (0.8) | 4.9 (1.3) | 5.6 (1.5) | 7.0 (1.8) | |
TLC (L) | 5.3 (1) | 6.5 (1.7) | 6.1 (0.7) | 8.3 (1.1) | 5.4 (0.8) | 7.3 (1.4) | 4.0 (1.0) | 5.1 (1.0) | 5.0 (1.0) | 6.4 (1.3) | |
RV (L) | 1.7 (0.6) | 2.1 (0.8) | 2.0 (0.5) | 2.5 (0.6) | 1.6 (0.5) | 2.1 (0.7) | 1.5 (0.5) | 1.8 (0.6) | 1.7 (0.6) | 2.5 (1.3) | |